Nat. Biotechnol.

Gilead's deal of a lifetime.

B Huggett, C Scott

Gilead Sciences' ascent to the upper echelon of biotech centered around one very savvy acquisition that launched an HIV franchise.

-Anti-HIV Agents (+administration & dosage; +economics)
-Drug Industry (+economics)
+Drug Therapy, Combination
-HIV Infections (-drug therapy)

pii:nbt0509-423
doi:10.1038/nbt0509-423
pubmed:19430443

